Génicado has received a minority investment from BNP Paribas Développement
Quentin and Martin d’Hermies have completed a primary minority LBO of Génicado with BNP Paribas Développement.
Génicado is a local champion for object and clothing personalization. Located in Nantes and with offices in Paris and Rennes, the company is a one-stop shop for its B2B clients who externalize their brand image.
BNP Paribas Développement, an autonomous subsidiary of the international banking group BNP Paribas, is a limited company which, for over 30 years, has been investing its own funds directly as a minority shareholder to support the development of successful SMEs and SMIs to ensure their long-term survival by facilitating their transfer. In addition to providing companies with stable financial resources, BNP Paribas Développement’s mission is to support the management teams over the long term as they implement their medium-term strategic projects. BNP Paribas Développement’s position as a minority shareholder ensures that its partners benefit from appropriate governance without interference in day-to-day management, while benefiting from the strength of a recognized group and the experience of a partner with a portfolio of over 500 diversified investments.
Oaklins’ team in France acted as the exclusive financial advisor to Génicado in this LBO.
Quentin and Martin d’Hermies
Owners, Génicado
Talk to the deal team
Related deals
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn moreMicrofinanciera Fundeser has been sold to Grupo Financiero Atlántida
Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.
Learn more